1,5-Diarylsubstituted 1,2,3-triazoles as potassium channel activators. VI

Farmaco. 2004 May;59(5):397-404. doi: 10.1016/j.farmac.2004.01.012.

Abstract

As part of our program toward designing potassium channel openers, synthesis of a novel series of 1,5-diphenylsubstituted 1,2,3-triazoles, as potential activators of the large-conductance calcium-activated potassium channels (BK), as well as their vasorelaxant activity are presented. The functional effect of these potential structurally novel BK-openers on vascular contractile function were studied in vitro, using isolated rat aortic rings pre-contracted with KCl 20 mM. Among the target compounds, only 16 showed appreciable effectiveness, exhibiting an efficacy parameter (57%) lower than that of NS1619 and a comparable potency index (pIC50: 5.58).

MeSH terms

  • Animals
  • Benzimidazoles
  • Inhibitory Concentration 50
  • Models, Chemical
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / physiology
  • Potassium Channels, Calcium-Activated / metabolism*
  • Rats
  • Triazoles / chemical synthesis
  • Triazoles / pharmacology*
  • Vasodilator Agents / chemical synthesis
  • Vasodilator Agents / pharmacology*

Substances

  • Benzimidazoles
  • Potassium Channels, Calcium-Activated
  • Triazoles
  • Vasodilator Agents
  • NS 1619